Method for simultaneously testing five nucleotides and five nucleosides
Through liquid chromatography-mass spectrometry and ultra-high performance liquid chromatography-quadrupole-electrostatic field orbital trap high-resolution mass spectrometry, the problem of nucleotides and nucleosides in the prior art is solved, and the problem of nucleotides and nucleosides cannot be detected simultaneously in infants and young children is realized The systematic evaluation of nucleotides and nucleosides in formula milk powder and formula foods for special medical purposes ensures technical support for quality control and evaluation.
Patent Information
- Application Number
- CN202411291791.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-14
- Publication Date
- 2024-12-06
AI Technical Summary
The prior art is difficult to detect nucleotides and nucleosides in infant formula and formula foods for special medical purposes at the same time, and cannot conduct systematic and comprehensive evaluation, resulting in the inability to accurately represent the nucleotide intake level of infants and young children.
Using liquid chromatography-mass spectrometry, the mobile phase composition is optimized by gradient elution and optimization, using Waters ACQUITY HSS T3 column and Q-Exactive high-resolution mass spectrometry system, combined with ultra-high performance liquid chromatography-quadrupole-electrostatic field orbital trap high-resolution Mass spectrometry to achieve quantitative and qualitative detection of 5 nucleotides and 5 nucleosides.
It realizes the simultaneous detection of nucleotides and nucleosides in infant formula and formula foods for special medical purposes, provides a systematic and comprehensive evaluation, and ensures technical support for quality control and evaluation.
Smart Images

Figure CN119086766A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of analysis and detection, and particularly relates to a method for simultaneously testing five kinds of nucleotides and five kinds of nucleosides. Background Art
[0002] Nucleotides (NTs) are essential nutrients for maintaining human metabolism. They can improve and enhance immunity, memory, anti-infection ability, and metabolic function. Adding them in appropriate amounts can help improve the intestinal flora of infants and promote the growth and development of the gastrointestinal tract. Nucleotides have the functions of promoting and improving intestinal function, promoting growth and development, repairing liver tissue damage, and improving the body's immunity. Therefore, nucleotides are considered to be an important type of effective factor component of functional foods. Adding nucleotides to dietary supplements and milk powder has become a consensus. Breast milk contains a variety of nucleotides, while cow's milk generally does not contain nucleotides. Therefore, nucleotides are often added to infant formula to approach the level of breast milk.
[0003] Nucleosides are composed of purine bases or pyrimidine bases and pentose. Nucleotides are phosphate esters of nucleosides, which are composed of purine bases or pyrimidine bases, ribose or deoxyribose and phosphate. The two are the basic building blocks of DNA and RNA, and play an important role in the chemical reaction process in the body. Under the action of biological enzymes and phosphatases, nucleotides ingested into the human body will be degraded into nucleosides and absorbed. Therefore, the "total available nucleoside substances" can be detected as a method for comprehensively evaluating the content of nucleotides. However, nucleotides and nucleosides have similar structures. Among the methods for detecting nucleotides, conventional detection methods are difficult to achieve effective separation. Ultraviolet spectrophotometry is complex to operate and is easily interfered by the matrix. It can only detect nucleotides but not nucleosides. Although ion chromatography is simple to operate and less interfered by the matrix, the mobile phase is incompatible with mass spectrometry and cannot be studied in depth. High performance liquid chromatography is the method used in the current standard GB 5413.40-2016 "National Food Safety Standard Determination of Nucleotides in Infant Food and Dairy Products", and it is also the most widely used method at present, with simple and efficient operation. However, as highly polar small molecule compounds, nucleosides are extremely weakly retained in traditional reversed-phase chromatography and are greatly affected by the matrix.
[0004] At present, the research on nucleotides in infant formula is still at the stage of free nucleotides. The existing standard GB5413.40-2016 "National Food Safety Standard Determination of Nucleotides in Infant Food and Dairy Products" only provides detection methods for five free nucleotides in the products. The research on detection methods for nucleotide synthetic metabolic components such as nucleic acids and amino acids is still insufficient. The sources of infant nucleotides include de novo synthesis and remedial synthesis. Only analyzing the free nucleotides in infant formula and special medical purpose formula cannot fully represent the infant nucleotide intake level, resulting in the inability to conduct a systematic and comprehensive evaluation of nucleotides in infant formula and special medical purpose formula.
[0005] Therefore, there is an urgent need to provide a detection method that can simultaneously analyze and detect nucleotides and nucleosides in infant formula and special medical purpose formula foods, and conduct a systematic and comprehensive evaluation of the nucleotides and nucleosides in the samples. Summary of the invention
[0006] The present invention aims to solve at least one of the technical problems existing in the above-mentioned prior art. To this end, the present invention proposes a method for simultaneously testing 5 nucleotides and 5 nucleosides. The method provided by the present invention can simultaneously analyze and detect nucleotides and nucleosides in infant formula milk powder and special medical purpose formula food, and systematically and comprehensively evaluate the nucleotides and nucleosides in the sample.
[0007] The invention provides a method for simultaneously testing five kinds of nucleotides and five kinds of nucleosides.
[0008] Specifically, a method for simultaneously testing 5 nucleotides and 5 nucleosides comprises the following steps:
[0009] Weigh uracil nucleotide, adenine nucleotide, cytosine nucleotide, inosine nucleotide, guanine nucleotide, uracil nucleoside, adenine nucleoside, cytosine nucleoside, inosine nucleoside and guanine nucleoside, and dissolve them in a solvent to prepare a reference solution;
[0010] Pre-treating the sample to be tested to obtain a sample solution;
[0011] Injecting the reference substance solution and the sample solution into a liquid chromatography-mass spectrometer for detection to obtain chromatograms of the reference substance and the sample; and performing qualitative or quantitative analysis based on the chromatograms;
[0012] In the detection process, a mobile phase is used for gradient elution, and the mobile phase includes 30-60 mmol / L ammonium acetate solution (mobile phase A) and methanol (mobile phase B); the process of the gradient elution is:
[0013] 0-0.1min, the volume percentage of methanol in the mobile phase is 0%;
[0014] 0.1-4.0 min, the volume percentage of methanol in the mobile phase increases from 0% to 28%-32%;
[0015] 4.0-7.0 min, the volume percentage of methanol in the mobile phase increases from 28%-32% to 58%-62%;
[0016] 7.0-7.1 min, the volume percentage of methanol in the mobile phase decreases from 58%-62% to 0%;
[0017] 7.1-12 min, the volume percentage of methanol in the mobile phase is 0%;
[0018] The chromatographic column is a Waters ACQUITY HSS T3 column.
[0019] In some embodiments of the present invention, the process of gradient elution is:
[0020] 0-0.1min, the volume percentage of methanol in the mobile phase is 0%;
[0021] 0.1-4.0 min, the volume percentage of methanol in the mobile phase increases from 0% to 30%;
[0022] 4.0-7.0 min, the volume percentage of methanol in the mobile phase increases from 30% to 60%;
[0023] 7.0-7.1 min, the volume percentage of methanol in the mobile phase decreases from 60% to 0%;
[0024] 7.1-12 min, the volume percentage of methanol in the mobile phase is 0%.
[0025] In some embodiments of the present invention, the pH of the ammonium acetate solution is 4.5-5.5.
[0026] In some embodiments of the present invention, the concentration of the ammonium acetate solution is 30 to 60 mmol / L;
[0027] In some embodiments of the present invention, during the detection process, the injection volume is 1-5 μL, the flow rate is 0.1-0.3 mL / min, and the column temperature is 35-45°C.
[0028] In some embodiments of the present invention, the pretreatment process is: dissolving the milk powder sample, then precipitating the protein with an acetic acid solution, filtering out the residue, and obtaining a sample solution.
[0029] Preferably, water is used to dissolve the milk powder sample.
[0030] Preferably, the mass percentage of the acetic acid solution is 10% to 60%; further preferably, the mass percentage of the acetic acid solution is 45% to 55%.
[0031] Preferably, the pH of the acetic acid solution is 4.0-5.0; more preferably, the pH of the acetic acid solution is 4.5.
[0032] In some embodiments of the present invention, the liquid chromatography-mass spectrometer includes a Q-Exactive high-resolution mass spectrometry system with transcendⅠ ultra-high performance liquid chromatography (ultra-high performance liquid chromatography-quadrupole-electrostatic field orbitrap high-resolution mass spectrometry, UPLC-Q-Exactive Orbitrap-MS) or a TSQ Quantis mass spectrometer with an Ultimate 3000 liquid chromatograph (liquid chromatography-tandem mass spectrometry, UPLC-MS / MS).
[0033] In some embodiments of the present invention, when the liquid chromatography-mass spectrometer is a Q-Exactive high-resolution mass spectrometry system equipped with transcendⅠ ultra-high performance liquid phase, the heated electrospray ion source HESI-Positive mode is adopted, and the primary full scan + DDA secondary daughter ion scan mode is adopted.
[0034] In some embodiments of the present invention, when the liquid chromatography-mass spectrometer TSQ Quantis mass spectrometer is equipped with an Ultimate 3000 liquid chromatograph, the electrospray positive ion mode (ESI+) is selected; the reaction monitoring mode scan (SRM) is selected; the spray voltage is 4000V; the sheath gas is 40Arb; the auxiliary gas is 10Arb; the capillary temperature is 350°C; the nebulization temperature is 350°C; the collision gas is 1.5mTorr; and the mass spectrometry scanning parameters are: Q1 and Q3 are both 0.7FWHM.
[0035] The present invention also provides an application of the method for simultaneously testing five nucleotides and five nucleosides.
[0036] Specifically, the above method of simultaneously testing 5 nucleotides and 5 nucleosides is used in evaluating and controlling the quality of infant formula milk powder and special medical purpose formula food.
[0037] In some embodiments of the present invention, the special medical purpose formula food includes lactose-free infant formula food, partially hydrolyzed infant milk protein formula food, deeply hydrolyzed infant milk protein formula food, etc.
[0038] The method provided by the present invention is to first dissolve the sample to be tested in water, precipitate the protein with an acetic acid solution and then filter, use a Waters HSS T3 column (2.1mm×100mm, 1.8μm) as an analytical column, and use a 30-60mmol / L ammonium acetate (pH=5.0) solution and methanol as mobile phases for gradient elution, which can simultaneously quantitatively and qualitatively detect 5 nucleotides and 5 nucleosides in the sample to be tested (such as infant formula milk powder, special medical formula food). The method is also applicable to liquid chromatography-tandem mass spectrometry (UPLC-MS / MS) and ultra-high performance liquid chromatography-quadrupole-electrostatic field orbital trap high-resolution mass spectrometry (UPLC-Q-Exactive Orbitrap-MS).
[0039] Compared with the prior art, the present invention has the following beneficial effects:
[0040] The method for simultaneously testing 5 nucleotides and 5 nucleosides provided by the present invention can simultaneously analyze 5 nucleotides and 5 nucleosides in milk powder; and is also applicable to liquid chromatography-tandem mass spectrometry (UPLC-MS / MS) and ultra-high performance liquid chromatography-quadrupole-electrostatic field orbital trap high-resolution mass spectrometry (UPLC-Q-Exactive Orbitrap-MS) for quantitative and qualitative analysis. The method provides technical support for the determination of nucleotide and nucleoside content in infant formula milk powder and special medical purpose formula foods, and provides technical guarantee for the evaluation and control of the quality of infant formula milk powder and special medical purpose formula foods. BRIEF DESCRIPTION OF THE DRAWINGS
[0041] Figure 1 Spectra of the five nucleotide standard working solutions in Example 1;
[0042] Figure 2 The spectra of the five nucleoside standard working solutions in Example 1 are as follows;
[0043] Figure 3 This is the separation spectrum of nucleotides when the first injection is performed in a 50 mmol / L ammonium acetate buffer (pH=5.0)-methanol system using a Waters ACQUITY HSS T3 chromatographic column in Example 2;
[0044] Figure 4 This is the separation spectrum of nucleosides when the first injection is made in a 50 mmol / L ammonium acetate buffer (pH=5.0)-methanol system using a Waters ACQUITY HSS T3 chromatographic column in Example 2;
[0045] Figure 5This is the separation spectrum of nucleotides when the second injection is performed in a 50 mmol / L ammonium acetate buffer (pH=5.0)-methanol system using a Waters ACQUITY HSS T3 chromatographic column in Example 2;
[0046] Figure 6 This is the separation spectrum of nucleosides when the second injection is performed in a 50 mmol / L ammonium acetate buffer (pH=5.0)-methanol system using a Waters ACQUITY HSS T3 chromatographic column in Example 2;
[0047] Figure 7 This is the separation spectrum of nucleotides using the C30 chromatographic column in the experimental example;
[0048] Figure 8 This is the separation spectrum of nucleosides when using the C30 chromatographic column in the experimental example;
[0049] Fig. 9 This is the separation spectrum of nucleotides when the first injection is made using a Waters ACQUITY HSS T3 column in a 0.1% formic acid acetonitrile-0.1% formic acid system in the experimental example;
[0050] Fig.10 This is the separation spectrum of nucleosides when the first injection is made in the experimental example using a Waters ACQUITY HSS T3 column in a 0.1% formic acid acetonitrile-0.1% formic acid system;
[0051] Fig.11 This is the separation spectrum of nucleotides when the second injection is performed in the system of 0.1% formic acid acetonitrile-0.1% formic acid using a Waters ACQUITY HSS T3 column in the experimental example;
[0052] Fig.12 This is the separation spectrum of nucleosides when the second injection is performed in the system of 0.1% formic acid acetonitrile-0.1% formic acid using a Waters ACQUITY HSS T3 column in the experimental example;
[0053] Fig.13 This is the separation spectrum of nucleotides in the experimental example using a Waters ACQUITY HSS T3 column in a 2mmol / L ammonium acetate buffer (pH=5.0)-methanol system;
[0054] Fig.14 This is the separation spectrum of nucleosides in the experimental example using a Waters ACQUITY HSS T3 column in a 2mmol / L ammonium acetate buffer (pH=5.0)-methanol system;
[0055] Fig.15This is the separation spectrum of nucleotides in the experimental example using a Waters ACQUITY HSS T3 column in a 20 mmol / L ammonium acetate buffer (pH = 5.0)-methanol system;
[0056] Fig.16 This is the separation spectrum of nucleosides in the experimental example using a Waters ACQUITY HSS T3 column in a 20 mmol / L ammonium acetate buffer (pH=5.0)-methanol system. DETAILED DESCRIPTION
[0057] In order to make the technical scheme of the present invention more clearly understood by those skilled in the art, the following embodiments are listed for illustration. It should be noted that the following embodiments do not limit the protection scope of the present invention.
[0058] Unless otherwise specified, the raw materials, reagents or devices used in the following examples or comparative examples can be obtained from conventional commercial sources or by existing known methods.
[0059] Example 1
[0060] 1 Reagents and Materials
[0061] 1.1 Reagents
[0062] Methanol (mass spectrometry grade), ammonium acetate (mass spectrometry grade), acetic acid (mass spectrometry grade): Shanghai Anpu Company; ultrapure water (resistivity 18.2 MΩ·cm) was used in the experiments.
[0063] 1.2 Reagent preparation
[0064] Preparation of 50% acetic acid solution: acetic acid: ultrapure water = 1:1 (volume ratio).
[0065] 50mmol / L ammonium acetate buffer (pH=5.0): Weigh 3.85g of ammonium acetate, add 980mL of deionized water to dissolve, adjust pH=5.0±0.05 with acetic acid, transfer to a 1000mL mobile phase bottle, and then make up to volume for later use.
[0066] 1.3 Standards
[0067] 5 kinds of nucleotide standards: uracil nucleotide (UMP, CAS No.3387-36-8, Shanghai ANPEL Company, purity 100%), adenine nucleotide (AMP, CAS No.61-19-8, Beijing Bepure Company, purity 99.4%), cytosine nucleotide (CMP, CAS No.63-37-6, Tianjin First Standard Company, purity 99.9%), inosine nucleotide (IMP, CAS No.352195-40-5, Tianjin First Standard Company, 99.9%) and guanine nucleotide (GMP, CAS No.5550-12-9, Shanghai ANPEL Company, 92.5%).
[0068] The five nucleoside standards include: uridine (U, CAS No. 58-96-8, Beijing Bepure Company, 99.7%), adenine (A, CAS No. 58-61-7, Beijing Bepure Company, 99.8%), cytosine (C, CAS No. 65-46-3, Sigma-Aldrich Company, USA, 99.6%), inosine (I, CAS No. 58-63-9, Guangzhou CATO Company, 99.9%) and guanosine (G, CAS No. 118-00-3, Tianjin First Standard Company, 99.9%).
[0069] 1.4 Preparation of standard solution
[0070] (1) Preparation of nucleotide and nucleoside standard stock solutions: Accurately weigh 10 mg of nucleotide and nucleoside reference substances respectively into a 10 mL brown volumetric flask, dissolve in ultrapure water, make up to volume, shake well, and prepare a stock solution with a concentration of 1 mg / mL. Seal and store in a -20°C refrigerator.
[0071] (2) Preparation of nucleotide and nucleoside mixed standard intermediate solution: Accurately pipette 0.1 mL of nucleotide and nucleoside standard stock solution into a 100 mL brown volumetric flask, dilute to volume with ultrapure water, shake well, and prepare a nucleotide and nucleoside mixed standard working solution with a concentration of 1 μg / mL. Prepare and use immediately.
[0072] (3) Preparation of mixed standard working solutions of nucleotides and nucleosides: Dilute the mixed standard intermediate solution with ultrapure water in stages as required to prepare mixed standard working solutions with concentrations of 10, 20, 30, 50, 100, 200, 300, 400, 500 and 600, which are prepared for immediate use.
[0073] 1.5 Preparation of sample solution
[0074] The sample to be tested (infant formula milk powder) was dissolved in water, and the protein was precipitated with 50% acetic acid solution. The pH of the sample solution was adjusted to 4.5. When the sample to be tested showed obvious flocculent protein precipitate by naked eye observation, it was filtered to obtain a sample solution.
[0075] 2 Instruments and equipment
[0076] 2.1 Instrument: Q-Exactive high-resolution mass spectrometry system with transcend Ⅰ ultra-high performance liquid chromatography (ThermoFisher, USA).
[0077] 2.2 Chromatographic conditions
[0078] Chromatographic column: Waters ACQUITY HSS T3 column (2.1×100mm, 1.8μm); mobile phase A was 50mmol / L ammonium acetate solution (pH=5.0), and B was methanol; injection volume: 3μL; flow rate: 0.2mL / min; mobile phase gradient was: 0~0.1min, 0%B; 0.1~4.0min, 0%~30%B; 4.0~7.0min, 30~60%B; 7.0~7.1min, 60%~0%B; 7.1~12min, 0%B; column temperature: 40℃.
[0079] 2.2 High-resolution mass spectrometry (UPLC-Q-Exactive Orbitrap-MS) conditions
[0080] Mass spectrometry primary full scan + DDA secondary daughter ion scan-positive ion mode: using heated electrospray ion source HESI-Positive mode, using primary full scan + DDA secondary daughter ion scan mode. Spray Voltage (kV): +3.8; Capillary temperature (℃): 320; Aux gas heater temperature (℃): 350; Sheath gas flow rate (Arb): 35; Aux gas flow rate (Arb): 8; S-lens RF level: 50; Mass range (m / z): 100-1000, Full ms resolution: 70000; MS / MS resolution: 17500; topN: 8; NCE / stepped NCE: 20, 40. The desolvation gas (nitrogen) flow rate is 750L / h, the desolvation gas temperature is 350℃, the source temperature is 120℃, and the capillary voltage is 2.5kV. The transmission collision energy is 2eV and the trap collision energy is 2eV for low energy scanning, and the transmission collision energy is 4-6eV and the trap collision energy is 6-15eV for high energy scanning. The scanning range is m / z 50-1000.
[0081] 3 Analysis steps
[0082] 3.1 Sample processing
[0083] Accurately weigh 5.0g of the mixed sample into a 100mL conical flask, fully dissolve it with 20mL of warm water, and cool it to room temperature. Adjust the pH to 4.5 with 50% acetic acid solution, transfer it to a 50mL volumetric flask, make up to volume with ultrapure water, and filter it. After the filtrate is diluted to an appropriate multiple, filter it with a 0.22μm filter membrane, and then inject it for analysis.
[0084] 3.2 Preparation of standard curve
[0085] The standard solution was measured on the machine according to the above recommended conditions, and the peak area was recorded. The peak area was used as the ordinate and the concentration of the standard working solution was used as the abscissa, and a linear equation was used to draw a standard curve.
[0086] 3.3 Determination of sample solution
[0087] The sample solution is injected into a high-resolution mass spectrometer, the peak area is recorded, and the concentration of each component in the sample solution is obtained from the standard curve.
[0088] 3.4 Presentation of analysis results
[0089] The content of each component in the sample is calculated according to the following formula:
[0090]
[0091] Where:
[0092] X——the content of 5 nucleotides or 5 nucleosides in the sample, in milligrams per kilogram (mg / kg);
[0093] c——Concentration of sugar in the sample, in milligrams per milliliter (ng / mL);
[0094] V——fixed volume, in milliliters (mL);
[0095] d——dilution multiple;
[0096] m——the mass of the sample, in grams (g);
[0097] 1000——Conversion factor.
[0098] 4 High-resolution mass spectrometry (UPLC-Q-Exactive Orbitrap-MS) detection results
[0099] According to the above conditions, the linear equation of the standard solution and the contents of 5 nucleotides and 5 nucleosides in the sample were obtained. At the same time, the spike recovery experiment and the quantitative limit of the method were performed. The results are shown in Tables 1 to 3.
[0100] Table 1 Linear range, linear equation, correlation coefficient and quantification limit of 5 nucleotides and 5 nucleosides
[0101]
[0102] Table 2 Actual sample test results
[0103]
[0104]
[0105] In order to verify the feasibility and accuracy of this method, three concentration gradient standard solutions were added, and the experiment was repeated 6 times for each concentration. The spike recovery rate experiment was carried out according to the above method. The relevant results are shown in Table 3.
[0106] Table 3 Average spike recovery and relative standard deviation (RSD) of the method (n=6)
[0107]
[0108] Note: The addition amount of spike levels 1, 2 and 3 is 10, 20 and 40 mg / kg respectively
[0109] It can be seen that the average spiked recovery rate of the target compound in this example is between 92.3% and 112%, the relative standard deviation RSD is between 0.22% and 2.51%, and the LOQ of the five nucleotides and five nucleosides is 0.1 mg / kg.
[0110] The prepared standard working solution was injected and analyzed under the above instrument conditions of high-resolution mass spectrometry (UPLC-Q-Exactive Orbitrap-MS). The results are as follows Figures 1-2 As shown, the peak order from top to bottom is: uracil nucleotide UMP, adenine nucleotide AMP, cytosine nucleotide CMP, inosine nucleotide IMP, guanine nucleotide GMP, uridine U, adenine A, cytosine C, inosine I and guanosine G.
[0111] This example establishes for the first time a method for simultaneously detecting 5 nucleotides and 5 nucleosides in infant formula milk powder by ultra-high performance liquid chromatography-quadrupole-electrostatic field orbital trap high-resolution mass spectrometry. The sample to be tested is precipitated with 50% (v / v) acetic acid for protein, fat and other impurities, filtered and diluted, and then directly injected. This method has the advantages of fast separation time and high resolution, and can be used for the detection of 5 nucleotides and 5 nucleosides in positive samples.
[0112] Example 2
[0113] 1 Reagents and Materials
[0114] Reagents and materials are the same as in Example 1.
[0115] 2 Instruments and equipment
[0116] 2.1 Instrument: TSQ Quantis mass spectrometer with Ultimate 3000 liquid chromatograph and Chromeleon workstation (Thermo-Fisher, USA).
[0117] 2.2 Chromatographic conditions
[0118] Chromatographic column: Waters ACQUITY HSS T3 column (2.1×100mm, 1.8μm); mobile phase A was 50mmol / L ammonium acetate solution (pH=5.0), and B was methanol; injection volume: 3μL; flow rate: 0.2mL / min; mobile phase gradient was: 0~0.1min, 0%B; 0.1~4.0min, 0%~30%B; 4.0~7.0min, 30~60%B; 7.0~7.1min, 60%~0%B; 7.1~12min, 0%B; column temperature: 40℃.
[0119] 2.3 Mass spectrometry (UPLC-MS / MS) conditions
[0120] Electrospray positive ion mode (ESI+); selected reaction monitoring mode scanning (SRM); spray voltage: 4000 V; sheath gas: 40 Arb; auxiliary gas: 10 Arb; capillary temperature: 350°C; nebulization temperature: 350°C; collision gas: 1.5 mTorr; mass spectrometry scanning parameters: Q1 and Q3 are both 0.7 FWHM; other mass spectrometry conditions are shown in Table 4.
[0121] Table 4 Mass spectrometry parameters for five nucleotides and five nucleosides detected in SRM mode
[0122]
[0123]
[0124] Note: *Quantitative ion pair.
[0125] 3 Analysis steps
[0126] The analysis steps are the same as those in Example 1.
[0127] 4 Mass spectrometry (UPLC-MS / MS) test results
[0128] The mixed standard working solution was injected into the LC-MS instrument to determine the peak area of the target compound. With the concentration of the standard working solution (ng / mL) as the horizontal coordinate and the peak area as the vertical coordinate, a standard curve was drawn for calculation to obtain the corresponding linear equation and correlation coefficient (Table 4). The linear range of the five nucleotides and five nucleosides was 10-600 ng / mL. Each target substance had a good linear relationship within its linear range (r>0.999), and the correlation coefficient r was between 0.9992 and 0.9998. The linearity of nucleotides was slightly better than that of nucleosides. A negative sample (a sample without nucleotides and nucleosides) was taken as the background, and an appropriate amount of mixed standard working solution was added. The detection limit (LOD) was calculated based on the content at S / N=3.0, and the quantitation limit (LOQ) was calculated based on the content at S / N=10. It can be measured that when the sample weight is 5.0 g and the fixed volume is 50 mL, the detection limit of 5 nucleotides and 5 nucleosides is 0.1-0.3 mg / kg, and the quantification limit is 0.2-1.0 mg / kg. The results are shown in Table 5.
[0129] Table 5 Linear range, linear equation, correlation coefficient, detection limit and quantification limit of 5 nucleotides and 5 nucleosides
[0130]
[0131] 5 g of negative sample was taken as background, and three levels of spikes were added at 10, 20 and 40 mg / kg, respectively. Each level was measured six times in parallel to evaluate the accuracy and precision of the method. The average spike recovery and relative standard deviation (RSD) of this method are shown in Table 6. The results obtained meet the requirements for daily sample testing.
[0132] Table 6 Average spike recovery and relative standard deviation (RSD) of the method (n=6)
[0133]
[0134]
[0135] Note: The added amounts of spiking levels 1, 2 and 3 are 10, 20 and 40 mg / kg respectively.
[0136] 4. Mass spectrometry (UPLC-MS / MS) conclusion
[0137] The prepared standard working solution was injected and analyzed under the above instrument conditions of mass spectrometry (UPLC-MS / MS). Two injections were made, each with a concentration of 600 ng / mL. The result of the first injection was as follows: Figures 3-4 As shown, the result of the second injection is as follows Figures 5-6 As shown. Figures 3 to 6It can be seen that the target peaks in the separation spectrum have good separation, basically no tailing, and each component is basically normally distributed. In addition, the retention times of the target peaks of the five nucleotides and five nucleosides injected successively are basically not offset, and the retention time difference does not exceed 0.02min.
[0138] Experimental example
[0139] (1) Research on pretreatment methods
[0140] During pretreatment, the protein in the sample to be tested (such as infant formula milk powder and special medical formula food samples) is mainly removed to prevent interference with the determination of nucleotides and nucleosides. In this study, the matrix interference was removed by adjusting the pH of the sample solution, and 10% acetic acid, 25% acetic acid, and 50% acetic acid were used to precipitate protein. During the experiment, it was found that when the pH of the sample solution was 4-5 (especially 4.5) during the protein precipitation process using acetic acid solution, the sample to be tested showed obvious flocculent protein precipitates by naked eye observation. The protein precipitation process of acetic acid solution is gentle and will not affect the determination of nucleotides and nucleosides. There is no significant difference in the precipitation of protein by acetic acid solutions of different concentrations, only the difference in dosage. The 45%-55% acetic acid solution (especially 50%) is used in the least amount and the pH adjustment speed is faster. Considering the economic cost and time saving, 45%-55% acetic acid solution was selected to adjust the pH of the sample solution to 4.0-5.0.
[0141] (2) Selection of chromatographic column
[0142] The chromatographic column is the core of separation technology. Different compounds are suitable for different chromatographic columns. Nucleotides and nucleosides are highly polar substances. It is difficult to achieve good retention and separation effects using ordinary reversed-phase chromatographic columns. Therefore, it is necessary to select a chromatographic column with strong retention ability for polar compounds.
[0143] In the experiment, the separation effect of C30 chromatographic column was compared and studied (other separation and detection conditions were the same as in Example 2). The prepared standard working solution was injected at a concentration of 600 ng / mL. The results are shown in Figures 7-8 As shown. Figures 7-8 It can be clearly seen that the target peak is severely split and the overall target peak shape is not normally distributed. Its separation effect is obviously inferior to that of Waters ACQUITY HSS T3 column.
[0144] The Waters ACQUITY HSS T3 column is a highly polar C18 column that can tolerate 100% pure water as a mobile phase and can tolerate low pH, making it suitable for multi-component, highly polar sample analysis. Because the 10 compounds detected simultaneously in the present invention are all soluble in water, the HSS T3 column is compatible with pure water phase and has a better separation effect. And by optimizing the mobile phase conditions, it can ensure that 5 nucleotides and 5 nucleosides are well separated within 12 minutes.
[0145] (3) Optimization of mobile phase selection
[0146] A. Comparative study of the separation effect of the eluent system of 0.1% formic acid acetonitrile-0.1% formic acid, the mobile phase A: 50mmol / L ammonium acetate solution (pH=5.0) and B: methanol in Example 2 were replaced with 0.1% formic acid acetonitrile and 0.1% formic acid, respectively, and the sample was injected twice, and the other conditions remained unchanged, and the separation and detection were performed. The standard substance spectrum of the first injection is as follows Fig. 9 , Fig.10 The second injection of the standard substance spectrum is shown in Fig.11 , Fig.12 As shown by Figures 9 to 12 It can be seen that the retention time of the target peaks of the five nucleotides and five nucleosides shifted to varying degrees when using the 0.1% formic acid acetonitrile-0.1% formic acid system, with the retention time difference ranging from 0.1 to 0.3 min; and the target peaks of UMP, IMP, and GMP were severely tailed, the target peak of IMP was cracked, and the resolution of the target peak of I was poor. Compared with the 0.1% formic acid acetonitrile-0.1% formic acid system, the separation effect was significantly improved when using the 50mmol / L ammonium acetate buffer (pH=5.0)-methanol system; and the problems of target peak tailing, poor resolution, and target peak cracking were all solved.
[0147] B. Comparison of 2mmol / L ammonium acetate buffer (pH=5.0)-methanol system, 20mmol / L ammonium acetate buffer (pH=5.0)-methanol system and 50mmol / L ammonium acetate buffer (pH=5.0)-methanol system
[0148] Fig.13 , Fig.14 This is the spectrum of the standard substance with a concentration of 600 ng / mL in a 2 mmol / L ammonium acetate buffer (pH = 5.0)-methanol system. It can be seen from the spectrum that the target peaks of the five nucleotides all have tailing to varying degrees, especially IMP, GMP, and AMP.
[0149] To improve the tailing of the nucleotide target peak, increase the concentration of ammonium acetate. Fig.15 , Fig.16This is the spectrum of the standard substance with a concentration of 600 ng / mL in a 20 mmol / L ammonium acetate buffer (pH=5.0)-methanol system. It can be seen from the spectrum that the tailing of CMP and UMP has improved, while IMP, GMP and AMP have slight tailing.
[0150] In summary, 50 mmol / L ammonium acetate buffer (pH=5.0)-methanol system is preferably used as the mobile phase.
[0151] The above-mentioned embodiments only express several implementation methods of the present invention, and the description thereof is relatively specific and detailed, but it cannot be understood as limiting the scope of the patent of the present invention. It should be pointed out that, for ordinary technicians in this field, several variations and improvements can be made without departing from the concept of the present invention, which all belong to the protection scope of the present invention. Therefore, the protection scope of the patent of the present invention shall be subject to the attached claims.
Claims
1. A method for simultaneously determining 5 nucleotides and 5 nucleosides, characterized in that: The following steps are involved: Weigh uracil nucleotide, adenine nucleotide, cytosine nucleotide, inosine nucleotide, guanine nucleotide, uracil nucleoside, adenine nucleoside, cytosine nucleoside, inosine nucleoside and guanine nucleoside, and dissolve them in a solvent to prepare a reference solution; Pre-treating the sample to be tested to obtain a sample solution; Injecting the reference substance solution and the sample solution into a liquid chromatography-mass spectrometer for detection to obtain chromatograms of the reference substance and the sample; and performing qualitative or quantitative analysis according to the chromatogram; In the detection process, a mobile phase is used for gradient elution, and the mobile phase includes 30-60 mmol / L ammonium acetate solution and methanol; the process of the gradient elution is: 0-0.1min, the volume percentage of methanol in the mobile phase is 0%; 0.1-4.0 min, the volume percentage of methanol in the mobile phase increases from 0% to 28%-32%; 4.0-7.0 min, the volume percentage of methanol in the mobile phase increases from 28%-32% to 58%-62%; 7.0-7.1 min, the volume percentage of methanol in the mobile phase decreases from 58%-62% to 0%; 7.1-12 min, the volume percentage of methanol in the mobile phase is 0%; The chromatographic column is a Waters ACQUITY HSS T3 column.
2. The method according to claim 1, characterized in that The process of gradient elution is: 0-0.1min, the volume percentage of methanol in the mobile phase is 0%; 0.1-4.0 min, the volume percentage of methanol in the mobile phase increases from 0% to 30%; 4.0-7.0 min, the volume percentage of methanol in the mobile phase increases from 30% to 60%; 7.0-7.1 min, the volume percentage of methanol in the mobile phase decreases from 60% to 0%; 7.1-12 min, the volume percentage of methanol in the mobile phase is 0%.
3. The method according to claim 1 or 2, characterized in that: The concentration of the ammonium acetate solution is 30-60 mmol / L.
4. The method according to claim 3, characterized in that The pH of the ammonium acetate solution is 4.5-5.
5.
5. The method according to claim 1 or 2, characterized in that: During the detection process, the injection volume is 1-5 μL, the flow rate is 0.1-0.3 mL / min, and the column temperature is 35-45° C.
6. The method according to claim 1 or 2, characterized in that: The pretreatment process is as follows: dissolving the sample to be tested, then using an acetic acid solution to precipitate protein, filtering out the residue, and obtaining a sample solution.
7. The method according to claim 6, characterized in that The mass percentage of the acetic acid solution is 10% to 60%; preferably, the mass percentage of the acetic acid solution is 45% to 55%.
8. The method according to claim 7, characterized in that The pH of the acetic acid solution is 4.0-5.
05.
9. The method according to claim 1 or 2, characterized in that: The liquid chromatography-mass spectrometer includes a Q-Exactive high-resolution mass spectrometer system equipped with a transcendⅠ ultra-high performance liquid phase or a TSQ Quantis mass spectrometer equipped with an Ultimate 3000 liquid chromatograph.
10. Use of the method for simultaneously testing five nucleotides and five nucleosides according to any one of claims 1 to 9 in evaluating and controlling the quality of infant formula milk powder and special medical purpose formula food.
Citation Information
Patent Citations
Method of using HPLC to measure nucleotides in infant formula
CN106226414A
Cited By
Method for rapidly and quantitatively detecting inosine in plant root exudates
CN120334405A
